For a succinct analysis of 1H 2024 venture investment and exit activity in life sciences and health care, take a look at HSBC’s Venture Healthcare Report, Shake it off: HSBC Innovation Banking Analysis, 1H 2024. Lead author Jonathan Norris and his team analyze early stage, venture deals, private M&A and IPO activity in Healthtech, Med Device, Biopharma, and Dx/Tools, in both the United States and Europe. The Report also provides a deep dive into growth and investment in computational biology.
Several key findings of the Report are:
- 1H 2024 investments in Healthtech reversed the 2023 decline with deal activity rising each quarter. The sector also experienced a surge in earlier-stage deals.
- Med device investments are reported to remain stable in large part to an increase in first-financing deals and dollars in 2Q 2024. An increase in early-stage investments in deals requiring robust clinical trials, particularly in neurology.
- For Biopharma, the Report highlights exists and a strong M&A market for growth in the sector. Investment in Biopharma reportedly increased by 35%, and there were 51 private deals exceeding $100 million.
- Dx/Tools sector experienced a decline in first-financing deals. A resurgence of growth investors for companies reaching commercialization provided a bright spot for this sector. Early-stage valuations are reported to remain strong but companies with “lofty” valuations from 2020-2021 experienced down or flat rounds.
The Report summarizes that 1H 2024 experienced increased investment across every analyzed sector with numerous investor-led financings. IPO interest increased in Biopharma as well as high deal-value private M&A.
Author(s)
Related Insights
October 26, 2026
Manufacturing Industry Advisor
BMW Update to Terms and Conditions of Purchase
BMW Group International (“BMW”) has announced updates to its standard Terms and Conditions for the Purchase of Production Materials and Automotive Components (“IPC”) that will take effect December 1, 2026. The IPC forms the foundational terms that apply to Purchase Orders, and many other contracts, issued by BMW. Therefore, it is critical that suppliers or prospective suppliers to BMW understand the obligations provided for in the IPC and how BMW is proposing to change those obligations in its most recent update.
October 26, 2026
Foley Viewpoints
California Restaurant Association Files New California EPR Lawsuit Built on an Untested State Constitutional Tax Theory
Producers covered by California’s SB 54 have spent months watching a 17-state coalition fight the law in federal court on federal theories. Now a new challenger has opened a second front, in state court, with an argument no one has tried yet: the California Constitution’s ban on private taxation.
October 26, 2026
Foley Viewpoints
Frozen Potato Ruling Highlights Data-Sharing Antitrust Risk
A Sept. 17 decision in In re: Frozen Potato Products Antitrust litigation highlights the antitrust risks that can arise when participants in a concentrated industry share market data through a benchmarking platform, even when the data are aggregated, anonymized and historical rather than current.